CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2009-10-01): Jaundice spread won't predict bilirubin levels

Clinical

Jaundice spread won't predict bilirubin levels

Last Updated: 2009-10-01 8:00:34 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Cephalocaudal jaundice progression does not correlate with bilirubin levels, especially in late-term premature infants, a new prospective study shows.

Visual assessment of jaundice has long been used to gauge newborns' risk for significant hyperbilirubinemia, but without strong evidence for the accuracy of this practice, Dr. Ron Keren of The Children's Hospital of Philadelphia and his team note in the September Archives of Disease in Childhood-Fetal and Neonatal Edition.

To investigate, the researchers had experienced nurses use the 5-point Kramer scale to rate the extent of cephalocaudal jaundice in 522 infants before discharge from the hospital. The nurses' appraisals were paired with bilirubin measurements obtained within 8 hours of the visual assessment.

Most of the assessments were done when the infants were between 40 and 53 hours old.

Correlation between the nurses' ratings and actual bilirubin concentration was moderate, the researchers found. Correlations were weaker for newborns less than 38 weeks gestational age (rho = 0.29) than for infants born at or beyond 38 weeks gestation (rho = 0.53).

Twenty infants developed bilirubin levels exceeding or within 1 mg/dL of the phototherapy threshold. According to the article, while the odds of significant hyperbilirubinemia increased by roughly 60% with each incremental increase in jaundice grade, "as a continuous predictor...jaundice grade had poor overall discriminatory power."

In contrast, a complete absence of jaundice was 95% sensitive and 99% specific for ruling out a likelihood of serious bilirubin elevation, leading the research team to write that "infants with absolutely no jaundice have a very low risk of developing significant hyperbilirubinemia."

Regarding the absence of jaundice, however, the authors caution that the negative predictive value might be lower in populations with a higher percentage of infants with hyperbilirubinemia.

Also, they note, none of the assessments in this study were done in infants less than 26 hours old. "Absence of jaundice in an infant discharged before 24 hours of age does not rule out the development of significant hyperbilirubinemia, and predischarge bilirubin screening is especially useful in that setting," the investigators point out.

Finally, they conclude, "lack of visible jaundice prior to discharge does not obviate the need for the recommended early post-discharge follow-up by primary care pediatricians."

Arch Dis Child Fetal Neonatal Ed 2009;94:F317-F322.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.